Drugs / Cocarboxylase
Cocarboxylase
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT07296354 Comparator | Jan 2026 → Feb 2028 expected | neuropathy, painful | Egyptian International Pharmaceutical Industries Co | Not yet recruiting | No outcome recorded |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cocarboxylase | “Cocarboxylase (Vitamin B1 derivative) - 50 mg Nicotinamide (Vitamin B3) - 20 mg Vitamin B12 (Cyanocobalamin) - 500 mcg” NCT07296354 ↗ |
| Known as | Cocarboxilasa | ChEMBL registry synonym — accepted as the source's own label CHEMBL1236376 ↗ |
| Known as | Cocarboxylase chloride | ChEMBL registry synonym — accepted as the source's own label CHEMBL1236376 ↗ |
| Known as | Cocarboxylase hydrochloride | ChEMBL registry synonym — accepted as the source's own label CHEMBL1236376 ↗ |
| Known as | Coenzymate | ChEMBL registry synonym — accepted as the source's own label CHEMBL1236376 ↗ |
| Known as | Pyrophosphoric ester of thiamine | ChEMBL registry synonym — accepted as the source's own label CHEMBL1236376 ↗ |
| Known as | Thiamine diphosphate | ChEMBL registry synonym — accepted as the source's own label CHEMBL1236376 ↗ |
| Known as | Thiamine pyrophosphate | ChEMBL registry synonym — accepted as the source's own label CHEMBL1236376 ↗ |
| Known as | Thiamine pyrophosphate chloride | ChEMBL registry synonym — accepted as the source's own label CHEMBL1236376 ↗ |
| Modality | Small molecule | — CHEMBL1236376 ↗ |